Philips announces the acquisition of Traxtal - a medical technologyinnovator in image-guided procedures
"Image-guided procedures are one of the most important breakthroughs in the healthcare industry in decades. This acquisition allows Philips to significantly enhance its abilities in this rapidly-emerging field, and will help us further realize our ambition to offer the best quality of care in the most efficient way possible," said Steve Rusckowski, Chief Executive Officer of Philips' Healthcare sector.
"Philips is already a leader in providing solutions that enable the opening of obstructed arteries under X-Ray guidance. The acquisition of Traxtal, with its innovative technologies in image-based navigation, opens up great opportunities for further cutting edge, minimally-invasive intervention and therapy solutions in combination with our other leading diagnostic and imaging products in Ultrasound, CT and MR. This is consistent with our care cycle approach in key strategic areas such as Women's Health, Oncology and Cardiology, extending our solutions beyond diagnosis into image guidance and therapy," Mr. Rusckowski continued.
Traxtal complements Philips' offering in the area of minimally-invasive procedures. Traxtal's navigation solution displays, during the procedure, the instrument's position, orientation, and trajectory on medical images such as Ultrasound or CT. An example is the radiofrequency ablation of liver tumors - during this procedure Traxtal's PercuNav system helps guide and monitor the positioning of the ablation needle towards the center of the lesion.
Traxtal, headquartered in Toronto, is a pioneer in the innovation, development and manufacturing of computer assisted soft tissue navigation technologies. Traxtal was founded in 1996 to develop advanced instrumentation for image guided intervention, and currently has 45 employees. Philips has had a partnership with Traxtal to provide integrated soft tissue therapeutic and diagnostic navigation solutions since 2006. Traxtal will become part of the Ultrasound business within the Philips Healthcare sector. Financial details of this agreement were not disclosed.
This release may contain certain forward-looking statements with respect to the financial condition, results of operations and business of Philips and certain of the plans and objectives of Philips with respect to these items. By their nature, forward-looking statements involve risk and uncertainty because they relate to events and depend on circumstances that will occur in the future and there are many factors that could cause actual results and developments to differ materially from those expressed or implied by these forward-looking statements.
Philips Deutschland GmbH
Royal Philips Electronics of the Netherlands (NYSE: PHG, AEX: PHI) is a diversified Health and Well-being company, focused on improving people's lives through timely innovations. As a world leader in healthcare, lifestyle and lighting, Philips integrates technologies and design into people-centric solutions, based on fundamental customer insights and the brand promise of "sense and simplicity". Headquartered in the Netherlands, Philips employs approximately 116,000 employees in more than 60 countries worldwide. With sales of EUR 26 billion in 2008, the company is a market leader in cardiac care, acute care and home healthcare, energy efficient lighting solutions and new lighting applications, as well as lifestyle products for personal well-being and pleasure with strong leadership positions in flat TV, male shaving and grooming, portable entertainment and oral healthcare. News from Philips is located at www.philips.com/newscenter.
Press releases you might also be interested in
Weitere Informationen zum Thema "Medizintechnik":
Spot an: Künstliche Intelligenz im Lichtschalter
Mediatek rüstet sich für die Post-Smartphone-Ära: Auf der CES hat das Unternehmen angekündigt, verstärkt Chips für Bereiche wie Daten-Switches, Automotive und auch KI-Lösungen für Edge-Geräte zu entwickeln.Weiterlesen